| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 83 |
| 1 | ADALIMUMAB | 82 |
| 2 | FLUOROURACIL | 53 |
| 3 | FLUOROURACIL CREAM, 0.5% | 51 |
| 4 | PREDNISONE | 47 |
| 5 | DICLOFENAC SODIUM | 43 |
| 6 | METHOTREXATE SODIUM | 42 |
| 7 | INFLIXIMAB | 41 |
| 8 | DICLOFENAC | 38 |
| 9 | RITUXIMAB | 38 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BERACTANT | 3 | 0.0081 |
| 1 | METHSCOPOLAMINE BROMIDE | 1 | 0.0069 |
| 2 | IBUPROFEN LYSINE | 3 | 0.0053 |
| 3 | DEMECLOCYCLINE | 1 | 0.0044 |
| 4 | AMPICILLIN AND SULBACTAM | 3 | 0.0034 |
| 5 | ILOPROST | 2 | 0.0021 |
| 6 | LEVOLEUCOVORIN INJECTION | 6 | 0.0020 |
| 7 | AMIKACIN SULFATE | 3 | 0.0017 |
| 8 | LEVOLEUCOVORIN | 6 | 0.0016 |
| 9 | RAMUCIRUMAB | 9 | 0.0014 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Surfactant [EPC] | 4 | 0.0034 |
| 1 | Prostacycline [EPC] | 2 | 0.0021 |
| 2 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 9 | 0.0014 |
| 4 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 5 | CD30-directed Immunoconjugate [EPC] | 11 | 0.0011 |
| 6 | Interferon gamma [EPC] | 1 | 0.0007 |
| 7 | Echinocandin Antifungal [EPC] | 5 | 0.0006 |
| 8 | Epidermal Growth Factor Receptor Antagonist [EPC] | 27 | 0.0006 |
| 9 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |